Alkaloids modulate motility, biofilm formation and antibiotic susceptibility of uropathogenic Escherichia coli

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Dusane, Devendra H ^a   Hosseinidoust, Zeinab ^a   Asadishad, Bahareh ^a   Tufenkji, Nathalie ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; AZITHROMYCIN; CIPROFLOXACIN; PIPERINE; RESERPINE; 1,3 BENZODIOXOLE DERIVATIVE; ADHESIN; ALKALOID; AMIDE; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; FLIC PROTEIN, E COLI; PIPERIDINE DERIVATIVE; PLANT EXTRACT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; DRUG PENETRATION; EXTRACELLULAR MATRIX; FIMA GENE; FLIC GENE; GENE EXPRESSION; MOTA GENE; MOTB GENE; NONHUMAN; PAPA GENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROPATHOGENIC ESCHERICHIA COLI; UVRY GENE; BACTERIUM ADHERENCE; CHEMISTRY; DRUG EFFECTS; FLAGELLUM; GENE EXPRESSION REGULATION; METABOLISM;

ESCHERICHIA COLI;

ADHESINS, BACTERIAL; ALKALOIDS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BENZODIOXOLES; BIOFILMS; ESCHERICHIA COLI PROTEINS; FLAGELLA; GENE EXPRESSION REGULATION, BACTERIAL; PIPERIDINES; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; RESERPINE; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84911448684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112093     Document Type: Article

References (51)

1. Dhakal BK, Kulesus RR, Mulvey MA (2008) Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 38: 2-11.
2. Hancock V, Ferrières L, Klemm P (2007) Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol Letters 267(1): 30-37.
3. Lane MC, Alteri CJ, Smith SN, Mobley HLT (2007a) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci USA 104: 16669-16674.
4. Wiles TJ, Kulesus RR, Mulvey MA (2008) Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 85: 11-19.
5. Trautner BW, Darouiche RO (2004) Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control 32(3): 177-183.
6. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12(4): 564-582.
7. Sharma A, Chandraker S, Patel VK, Ramteke P (2009) Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections. Indian J Pharm Sci 71(2): 136-139.
8. Williams DH, Schaeffer AJ (2004) Current concepts in urinary tract infections. Minerva Urol Nefrol 56(1): 15-31.
9. Hidalgo G, Chan M, Tufenkji N (2011) Inhibition of Escherichia coli CFT073 fli C expression and motility by cranberry materials. Appl Environ Microbiol 77(19): 6852-6857.
10. Asadishad B, Hidalgo G, Tufenkji N (2012) Pomegranate materials inhibit flagellin gene expression and flagellar-propelled motility of uropathogenic Escherichia coli strain CFT073. FEMS Microbiol Lett 334(2): 87-94.
11. O9May C, Ciobanu A, Lam H, Tufenkji N (2012) Tannin derived materials can block swarming motility and enhance biofilm formation in Pseudomonas aeruginosa . Biofouling 28(10): 1063-1076.
12. Wink M (2008) Ecological roles of alkaloids. In Fattorusso E, Taglialatela-Scafati O, Eds. Modern alkaloids: structure, isolation, synthesis and biology. Wiley- VCH, Verlag GmbH & Co.3-24.
13. Srinivasan K (2007) Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr. 47(8): 735-48.
14. Abubacker MN, Vasantha S (2011) Antibacterial activity of ethanolic leaf extract of Rauwolfia tetraphylla (Apocyanaceae) and its bioactive compound reserpine. Drug Invent Today 3(3): 16-17.
15. Desai MG, Palaniyamma D (2012) A clinical review on a polyherbal formulation, Renalka syrup in urinary tract infection. Indian J Clin Practice. 22(12): 11-16.
16. Chagnot C, Zorgani MA, Astruc T, Desvaux M (2013) Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective. Front Microbiol 4: 303. doi: 10.3389/fmicb.2013.00303
17. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284(5418): 1318-1322.
18. Donlan RM, Costerton JW (2002) Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15(2): 167-193.
19. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45(4): 999-1007.
20. Corona F, Martinez JL (2013) Phenotypic resistance to antibiotics. Antibiotics 2: 237-255.
21. Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 47(1): 317-323.
22. Anderl JN, Franklin MJ, Stewart PS (2000) Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 44(7): 1818-1824.
23. Stewart PS (2002) Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292: 107-113.
24. Singh R, Ray P, Das A, Sharma M (2010) Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 65(9): 1955-1958.
25. Pratt LA, Kolter R (1998) Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 30(2): 285-293.
26. Mitra A, Palaniyandi S, Herren CD, Zhu X, Mukhopadhyay S (2013) Pleiotropic roles of uvrY on biofilm formation, motility and virulence in uropathogenic Escherichia coli CFT073. PLoS One 8(2): e55492.
27. Beloin C, Valle J, Latour-Lambert P, Faure P, Kzreminski M, et al. (2004) Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression. Mol Microbiol 51(3): 659-74.
28. Macnab RM (1992) Genetics and biogenesis of bacterial flagella. Annu Rev Genet 26: 131-158.
29. Kearns DB (2010) A field guide to bacterial swarming motility. Nat Rev Micro 8: 634-644.
30. Ferrieres L, Clarke DJ (2003) The RcsC sensor kinase is required for normal biofilm formation in Escherichia coli K-12 and controls the expression of a regulon in response to growth on a solid surface. Mol Microbiol 50: 1665-1682.
31. Girgis HS, Liu Y, Ryu WS, Tavazoie S (2007) A comprehensive genetic characterization of bacterial motility. PLoS Genet 9: e154.
32. Guttenplan SB, Kearns DB (2013) Regulation of flagellar motility during biofilm formation. FEMS Microbiol Rev 37(6): 849-871.
33. Wolfe AJ, Berg HC (1989) Migration of bacteria on semisolid agar. Proc Natl Acad Sci USA 86(18): 6973-6977.
34. O9Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, et al. (1999) Genetic approaches to the study of biofilms. Methods Enzymol 310: 91-109.
35. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
36. Hosseinidoust Z, Tufenkji N, van de Van TGM (2013) Formation of biofilms under phage predation: considerations concerning a biofilm increase. Biofouling 29(4): 457-468.
37. Dunne WM (1990) Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci. Antimicrob Agents Chemother 34(3): 390-393.
38. Lane M, Simms AN, Mobley HLT (2007b) Complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol 189: 5523-5533.
39. Stock J, Surette M (1994) Bacterial chemotaxis: the motor connection. Curr Biol 4(2): 143-144.
40. Daniels R, Vanderleyden J, Michiels J (2004) Quorum sensing and swarming migration in bacteria. FEMS Microbiol Rev 28: 261-289.
41. Domka J, Lee J, Bansal T, Wood TK (2007) Temporal gene-expression in Escherichia coli K-12 biofilms. Environ Microbiol 9: 332-346.
42. Serra DO, Richter AM, Klauck G, Mika F, Hengge R (2013) Microanatomy at cellular resolution and spatial order of physiological differentiation in a bacterial biofilm. mBio 19;4(2): e00103-13.
43. Pesavento C, Becker G, Sommerfeldt N, Possling A, Tschowri N, et al. (2008) Inverse regulatory coordination of motility and curli-mediated adhesion in Escherichia coli. Genes Dev 22(17): 2434-2446.
44. Jones BV, Young R, Mahenthiralingam E, Stickler DJ (2004) Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. Infect Immun 72(7): 3941-3950.
45. Boll EJ, Struve C, Boisen N, Olesen B, Stahlhut SG, et al. (2013) Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect Immun 81(4): 1164-1171.
46. Hoffman LR, D9Argenio DA, MacCoss MJ, Zhang Z, Jones RA, et al. (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436: 1171-1175.
47. Khan IA, Mirza ZM, Kumar A, Verma V, Qazi GN (2006) Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 50(2): 810-812.
48. Han HK (2011) The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin Drug Metab Toxicol 7(6): 721-729.
49. Atal CK, Dubey RK, Singh J (1985) Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 232: 258-262.
50. Badmaev V, Majeed M, Norkus EP (1999) Piperine, an alkaloid derived from black pepper, increases serum response of b-carotene during 14 days of oral bcarotene supplementation. Nutr Res 19: 381-388.
51. Singh M, Varshneya C, Telang RS, Srivastava AK (2005) Alteration of oxytetracycline following oral administration of Piper longum in hens. J Vet Sci 6(3): 197-200.